EA200601471A1 - Ингибиторы клеточной пролиферации клеток (варианты), фармацевтическая композиция на их основе, способ уничтожения раковых клеток (варианты) и способ лечения и профилактики злокачественных состояний (варианты) - Google Patents
Ингибиторы клеточной пролиферации клеток (варианты), фармацевтическая композиция на их основе, способ уничтожения раковых клеток (варианты) и способ лечения и профилактики злокачественных состояний (варианты)Info
- Publication number
- EA200601471A1 EA200601471A1 EA200601471A EA200601471A EA200601471A1 EA 200601471 A1 EA200601471 A1 EA 200601471A1 EA 200601471 A EA200601471 A EA 200601471A EA 200601471 A EA200601471 A EA 200601471A EA 200601471 A1 EA200601471 A1 EA 200601471A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- prevention
- malances
- options
- variants
- basis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54372404P | 2004-02-11 | 2004-02-11 | |
| US55580304P | 2004-03-24 | 2004-03-24 | |
| PCT/US2005/004759 WO2005086638A2 (fr) | 2004-02-11 | 2005-02-11 | Analogues inhibiteurs de la proliferation cellulaire, leurs procedes de fabrication, et leurs utilisations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA200601471A1 true EA200601471A1 (ru) | 2007-10-26 |
Family
ID=34976061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200601471A EA200601471A1 (ru) | 2004-02-11 | 2005-02-11 | Ингибиторы клеточной пролиферации клеток (варианты), фармацевтическая композиция на их основе, способ уничтожения раковых клеток (варианты) и способ лечения и профилактики злокачественных состояний (варианты) |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1723127A4 (fr) |
| JP (1) | JP2007522247A (fr) |
| AU (1) | AU2005220705A1 (fr) |
| BR (1) | BRPI0507612A (fr) |
| CA (1) | CA2559333A1 (fr) |
| EA (1) | EA200601471A1 (fr) |
| IL (1) | IL177444A0 (fr) |
| WO (1) | WO2005086638A2 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101395146B1 (ko) * | 2011-02-09 | 2014-05-16 | 부산대학교 산학협력단 | 피부미백, 항산화 및 ｐｐａｒ 활성을 갖는 신규 화합물 및 이의 의학적 용도 |
| WO2014066613A2 (fr) * | 2012-10-26 | 2014-05-01 | Zhejiang University | Mimétiques de métabolites sphingolipidiques |
| CN105246483A (zh) | 2013-03-15 | 2016-01-13 | 癌症研究技术有限责任公司 | 用于γ-谷氨酰循环调节的方法和组合物 |
| WO2023170024A1 (fr) * | 2022-03-11 | 2023-09-14 | University Of Copenhagen | Modulateurs de camk2 et leur utilisation en médecine |
| CN115894398B (zh) * | 2022-12-02 | 2024-03-12 | 青岛科技大学 | 一种含氟噻唑酰胺类杀虫杀螨剂 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2058260T3 (es) * | 1987-03-24 | 1994-11-01 | Nippon Chemiphar Co | Un proceso para la preparacion de un derivado del glicerol. |
| US4826990A (en) * | 1987-09-30 | 1989-05-02 | American Home Products Corporation | 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents |
| US5149704A (en) * | 1991-05-03 | 1992-09-22 | Abbott Laboratories | Platelet activating antagonists |
| FR2678938B1 (fr) * | 1991-07-10 | 1993-10-08 | Rhone Poulenc Rorer Sa | Derives de pyrrolidine, leur preparation et les medicaments les contenant. |
| FR2700168B1 (fr) * | 1993-01-07 | 1995-02-03 | Rhone Poulenc Rorer Sa | Dérivés de thiazolidine, leur préparation et les médicaments les contenant. |
| DE19546918A1 (de) * | 1995-12-15 | 1997-06-19 | Bayer Ag | Bicyclische Heterocyclen |
-
2005
- 2005-02-11 CA CA002559333A patent/CA2559333A1/fr not_active Abandoned
- 2005-02-11 WO PCT/US2005/004759 patent/WO2005086638A2/fr active Search and Examination
- 2005-02-11 AU AU2005220705A patent/AU2005220705A1/en not_active Abandoned
- 2005-02-11 JP JP2006553347A patent/JP2007522247A/ja not_active Withdrawn
- 2005-02-11 EA EA200601471A patent/EA200601471A1/ru unknown
- 2005-02-11 BR BRPI0507612-9A patent/BRPI0507612A/pt not_active IP Right Cessation
- 2005-02-11 EP EP05749117A patent/EP1723127A4/fr not_active Withdrawn
-
2006
- 2006-08-10 IL IL177444A patent/IL177444A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2559333A1 (fr) | 2005-09-22 |
| JP2007522247A (ja) | 2007-08-09 |
| EP1723127A4 (fr) | 2009-10-28 |
| IL177444A0 (en) | 2006-12-10 |
| WO2005086638A3 (fr) | 2005-11-24 |
| WO2005086638A2 (fr) | 2005-09-22 |
| AU2005220705A1 (en) | 2005-09-22 |
| BRPI0507612A (pt) | 2007-07-03 |
| EP1723127A2 (fr) | 2006-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2017019I2 (no) | Enzalutamid eller et farmasøytisk akseptabelt salt derav | |
| NO20061197L (no) | Proteasominhibitorer og fremgangsmater for anvendelse av samme | |
| HK1089153A1 (en) | Proteasome inhibitors and methods of using the same | |
| MX2021008610A (es) | Tratamiento del cancer usando combinaciones de inhibidores de erk y raf. | |
| TWI367886B (en) | Proteasome inhibitors and methods of using the same | |
| ATE408412T1 (de) | Verwendung von cannabidiol zur hemmung von gehirntumorzellmigration | |
| IN2012DN01964A (fr) | ||
| ATE419249T1 (de) | Inhibitoren von mitotischem kinesin | |
| MY169330A (en) | Method for inhibition of deubiquitinating activity | |
| EA200601471A1 (ru) | Ингибиторы клеточной пролиферации клеток (варианты), фармацевтическая композиция на их основе, способ уничтожения раковых клеток (варианты) и способ лечения и профилактики злокачественных состояний (варианты) | |
| MX2008013017A (es) | Tratamiento de malignidades hematologicas con fts y un inhibidor de tirosina cinasa de bcr-abl. | |
| WO2008134752A3 (fr) | Méthodes et compositions pour traiter le cancer | |
| UA88771C2 (ru) | Ингибиторы протеасомы и способ их применения (варианты) | |
| DE60311788D1 (de) | Kombinationstherapie zur behandlung von krebs | |
| EA201170127A1 (ru) | АНТАГОНИСТЫ РНК, НАЦЕЛЕННЫЕ НА Hsp27 | |
| NZ597948A (en) | Combinations for the treatment of diseases involving cell proliferation | |
| EA200600987A1 (ru) | Применение сирамезина в лечении злокачественных опухолей |